---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-24-035171"
form_type: "8-K"
ticker: "AGL"
cik: "0001831097"
company_name: "agilon health, inc."
filed_at: "2024-08-06T23:59:59+00:00"
generated_at: "2026-05-31T12:34:51.136289+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# agilon health Q2 revenue up 39% to $1.48B but net loss widens to $31M

## Summary
- Revenue $1.48B (+39% YoY); MA membership 513K (+38%).
- Net loss $31M vs $17M loss year ago; gross profit fell to $32M from $55M.
- Medical margin $106M (down 21% YoY); Adjusted EBITDA loss $3M vs $12M gain.
- Retroactive termination of unprofitable contracts cut membership by 17K and revenue by $110M.
- Maintains FY2024 medical margin ($400-450M) and Adjusted EBITDA (-$60 to -$15M) guidance.

## SEC filing metadata
- accession: 0001628280-24-035171
- form_type: 8-K
- ticker: AGL
- cik: 0001831097
- company_name: agilon health, inc.
- filed_at: 2024-08-06T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1831097/000162828024035171/0001628280-24-035171-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1831097/000162828024035171/agl-20240806.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-24-035171
- JSON: https://secwatch.observer/filing/0001628280-24-035171.json
- Plain text: https://secwatch.observer/filing/0001628280-24-035171.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.